Veeva Systems provides cloud software and data services purpose-built for life sciences companies. Its Commercial Cloud offerings support pharmaceutical CRM, customer engagement, and industry data, while Veeva Vault manages clinical, regulatory, quality, safety, and content processes. The company earns recurring software subscription revenue and professional services fees from pharmaceutical and biotechnology customers.
Veeva Systems Inc. (VEEV) has a MarketKingdoms composite score of 70.6 (B+), an B-range rating. It ranks 267th of 1,866 covered companies, 10th of 78 in Healthcare (sector average 64.5) and 1st of 1 in Health Information Services. Scores as of 2026-10-25.
Its strongest lenses are Industry opportunity at 87 (Healthcare average 81) and Quality (profitability) at 80 (Healthcare average 50). Its weakest lenses are Price (valuation) at 23 (sector average 50) and Catalyst watch at 41 (sector average 74).
| Lens | Type | VEEV | Healthcare average | Health Information Services average | Percentile in sector |
|---|---|---|---|---|---|
| Industry opportunity | Research signal | 87 | 81 | 87 | 78th |
| Stock selection | Research signal | 71 | 79 | 71 | 15th |
| KPI momentum | Research signal | 75 | 78 | 75 | 36th |
| Catalyst watch | Research signal | 41 | 74 | 41 | 3rd |
| Price (valuation) | Fundamental lens | 23 | 50 | 23 | 17th |
| Expansion (growth) | Fundamental lens | 77 | 50 | 77 | 90th |
| Quality (profitability) | Fundamental lens | 80 | 50 | 80 | 94th |
| Trend (momentum) | Fundamental lens | 70 | 50 | 70 | 77th |
The most recent call analysed was held on 2026-08-26 (fiscal 2027 Q2). MarketKingdoms checks what management promised on each call against what it later delivered.
The stock's valuation gap is +11.2%: its price is above the path its market, sector and industry moves explain (overvalued versus the model path). Factor sensitivity: market beta 1.62, sector beta 0.46, industry beta 0.00; the factor model explains 13% of its moves (R²).
Veeva Systems Inc. financial statements · Healthcare sector ranking · Health Information Services industry ranking · All covered companies
The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.
General information, not investment advice.